— Know what they know.
Not Investment Advice

ALKS NASDAQ

Alkermes plc
1W: +0.5% 1M: +10.4% 3M: -8.3% YTD: +56.8% 1Y: +48.7% 3Y: +64.0% 5Y: +42.9%
$44.32
-0.12 (-0.27%)
After Hours: $44.88 (+0.55, +1.25%)
Weekly Expected Move ±4.8%
$39 $42 $44 $46 $48
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Buy · Power 73 · $7.4B mcap · 155M float · 1.33% daily turnover · Short 61% of daily vol
Credit Risk of going bust: lower than 62% of companies Debt: 17.4% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.75 (down 98%), Alkermes plc would be worth roughly what it owes.
Total debt $1.57B against a stock market value of $7.46B.
Distance to default 6.43 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $764.8M (short-term plus half of long-term), stock volatility 40.1%; Altman Z'' 1.67. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
65.9 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: 2.9%  ·  5Y Avg: 12.5%
Cost Advantage
67
Intangibles
75
Switching Cost
61
Network Effect
55
Scale
68
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ALKS has a Narrow competitive edge (65.9/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Intangible Assets. ROIC of 2.9% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$50
Low
$57
Avg Target
$65
High
Based on 3 analysts since Jul 28, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 16Hold: 10Sell: 3Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$56.67
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-16 Truist Financial — Initiated $55 — +37.2% $40.10
2026-09-24 Goldman Sachs — $35 $50 +15 +18.7% $42.13
2026-07-28 Piper Sandler David Amsellem $45 $65 +20 +23.3% $52.73
2026-07-20 Stifel Nicolaus Paul Matteis $36 $63 +27 +19.5% $52.72
2026-07-02 Mizuho Securities Vamil Divan $45 $65 +20 +25.7% $51.72
2026-06-18 Needham Ami Fadia $50 $54 +4 +21.3% $44.51
2026-06-09 RBC Capital Leonid Timashev $47 $56 +9 +27.0% $44.08
2026-05-06 Needham — $43 $50 +7 +40.4% $35.62
2026-02-26 H.C. Wainwright Douglas Tsao $46 $43 -3 +38.5% $31.04
2026-02-23 Wolfe Research — Initiated $45 — +39.8% $32.19
2025-10-28 Jefferies Akash Tewari $50 $56 +6 +82.1% $30.75
2025-10-27 Mizuho Securities — $40 $45 +5 +51.2% $29.76
2025-10-23 Piper Sandler David Amsellem $37 $45 +8 +44.7% $31.09
2025-10-22 RBC Capital — $44 $47 +3 +51.2% $31.09
2025-09-26 RBC Capital Alkermes to Outperform Initiated $44 — +56.3% $28.14
2025-09-09 Needham — Initiated $43 — +54.4% $27.85
2025-09-09 H.C. Wainwright Douglas Tsao $37 $46 +9 +65.7% $27.77
2025-09-02 Wells Fargo — Initiated $44 — +49.7% $29.40
2025-06-17 UBS Ashwani Verma Initiated $42 — +41.1% $29.77
2024-12-05 Piper Sandler David Amsellem Initiated $37 — +18.4% $31.25
2024-11-13 Mizuho Securities Vamil Divan $35 $40 +5 +53.4% $26.07
2024-11-04 Stifel Nicolaus Paul Matteis $25 $36 +11 +35.4% $26.59
2024-10-24 Stifel Nicolaus Paul Matteis Initiated $25 — -6.9% $26.85
2024-10-14 H.C. Wainwright Douglas Tsao Initiated $37 — +28.0% $28.91
2024-04-10 Jefferies Akash Tewari $25 $50 +25 +274.0% $13.37
2024-04-09 Mizuho Securities Vamil Divan Initiated $35 — +30.9% $26.73
2024-04-09 Jefferies Akash Tewari Initiated $25 — -7.2% $26.95
2024-03-18 Robert W. Baird Joel Beatty Initiated $37 — +34.4% $27.53
2022-12-06 J.P. Morgan — Initiated $29 — +16.0% $25.00
2022-04-28 Leerink Partners — $25 $27 +2 -11.1% $30.38
2022-04-21 Leerink Partners — Initiated $25 — -15.0% $29.40
2022-04-20 Goldman Sachs — Initiated $35 — +22.9% $28.48

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
Oct 27, 2026
DCF
4
ROE
2
ROA
3
D/E
1
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ALKS receives an overall rating of C+. Strongest factors: DCF (4/5). Areas of concern: ROE (2/5), D/E (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-10-22 B- C+
2026-10-12 B B-
2026-10-02 B- B
2026-07-01 B B-
2026-05-05 A B
2026-04-28 A- A
2026-04-01 A A-
2026-03-05 A- A
2026-03-05 A A-
2026-03-04 A- A

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 41 Grade B
Profitability
27
Balance Sheet
53
Earnings Quality
64
Growth
29
Value
40
Momentum
61
Safety
65
Cash Flow
50
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ALKS scores highest in Safety (65/100) and lowest in Profitability (27/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.50
Grey Zone
Piotroski F-Score
4/9
✓ ✓ ✗ ✓ ✗ ✗ ✓ ✗ ✗
Beneish M-Score
-0.83
Possible Manipulator
Ohlson O-Score
-6.92
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BBB-
Score: 53.5/100
Trend: Deteriorating
Earnings Quality
75/100
OCF/NI: 3.80x
Accruals: -5.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ALKS scores 2.50, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ALKS scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ALKS's score of -0.83 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ALKS's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ALKS receives an estimated rating of BBB- (score: 53.5/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ALKS's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
110.13x
PEG
-1.35x
P/S
4.46x
P/B
4.09x
P/FCF
39.39x
P/OCF
34.76x
EV/EBITDA
44.24x
EV/Revenue
5.78x
EV/EBIT
61.67x
EV/FCF
43.52x
Earnings Yield
0.76%
FCF Yield
2.54%
Shareholder Yield
0.67%
Graham Number
$9.85
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 110.1x earnings, ALKS is priced for high growth expectations. Graham's intrinsic value formula yields $9.85 per share, 350% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.679
NI / EBT
×
Interest Burden
0.622
EBT / EBIT
×
EBIT Margin
0.094
EBIT / Rev
×
Asset Turnover
0.502
Rev / Assets
×
Equity Multiplier
1.936
Assets / Equity
=
ROE
3.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ALKS's ROE of 3.9% is driven by Asset Turnover (0.502), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$3.37
Price/Value
15.53x
Margin of Safety
-1453.35%
Premium
1453.35%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ALKS's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. ALKS trades at a 1453% premium to its adjusted intrinsic value of $3.37, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 110.1x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$44.32
Median 1Y
$45.64
5th Pctile
$23.83
95th Pctile
$87.39
Ann. Volatility
39.5%
Analyst Target
$56.67
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Richard F. Pops
Chief Executive Officer and Chairman
$1,250,769 $— $7,915,081
Blair C. Jackson
Executive Vice President, Chief Operating Officer; Former Interim Principal Financial Officer
$736,450 $1,333,356 $4,030,905
Joshua Reed President,
e President, Chief Financial Officer
$181,978 $1,155,031 $3,797,074
Craig C. Hopkinson,
M.D. Executive Vice President, Research and Development and Chief Medical Officer
$764,837 $1,100,001 $3,617,908
David J. Gaffin
Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary
$684,497 $1,100,001 $3,470,083
C. Todd Nichols
Senior Vice President, Chief Commercial Officer
$614,869 $866,683 $2,790,694

CEO Pay Ratio

23:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $7,915,081
Avg Employee Cost (SGA/emp): $342,206
Employees: 2,050

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
2,050
+13.9% YoY
Revenue / Employee
$719,951
Rev: $1,475,899,000
Profit / Employee
$117,885
NI: $241,664,000
SGA / Employee
$342,206
Avg labor cost proxy
R&D / Employee
$158,031
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -8.4% -4.4% -5.8% -8.6% -12.1% -14.7% -15.8% 8.7% 17.9% 31.7% 38.4% 22.5% 25.2% 27.5% 25.5% 24.0% 22.4% 14.7% 9.4% 3.9% 3.85%
ROA -4.7% -2.4% -3.2% -4.8% -6.6% -7.9% -8.4% 5.0% 10.2% 17.4% 21.5% 13.1% 15.0% 17.5% 16.8% 15.6% 15.1% 10.5% 4.8% 2.0% 1.99%
ROIC -5.2% -2.3% -3.2% -6.7% -10.7% -13.8% -12.5% 21.7% 38.5% 78.1% 76.5% 62.0% 64.2% 44.7% 46.9% 46.6% 43.6% 37.0% 5.1% 2.9% 2.92%
ROCE -4.6% -1.8% -3.7% -6.3% -9.1% -10.5% -8.2% 11.8% 20.5% 35.2% 37.7% 27.4% 28.2% 29.3% 26.8% 24.1% 21.9% 15.3% 6.5% 4.2% 4.19%
Gross Margin 83.2% 83.5% 80.2% 78.9% 79.9% 82.3% 79.8% 89.8% 83.9% 81.4% 83.3% 84.6% 83.3% 85.6% 83.9% 87.3% 86.9% 88.0% 84.3% 80.2% 80.22%
Operating Margin -6.7% 0.7% -9.5% -12.5% -24.0% -6.8% -3.8% 45.6% 23.4% 47.3% 12.4% 27.5% 27.7% 37.8% 4.5% 23.8% 22.6% 15.1% -12.3% 3.7% 3.71%
Net Margin -9.9% 0.3% -12.9% -10.9% -25.4% -9.3% -14.5% 38.4% 12.5% 29.9% 10.5% 22.9% 24.4% 34.1% 7.3% 22.3% 21.0% 12.8% -16.9% 0.1% 0.10%
EBITDA Margin -1.6% 7.3% -8.4% -4.2% -17.5% 0.9% 4.4% 49.6% 30.8% 54.8% 17.4% 32.4% 32.6% 42.2% 10.7% 28.8% 27.6% 19.9% -5.5% 11.0% 10.95%
FCF Margin 10.0% 6.3% 11.7% 8.7% 1.2% -1.5% -5.3% 10.9% 16.0% 21.2% 22.8% 21.7% 20.9% 26.0% 31.8% 31.9% 32.3% 32.5% 14.2% 13.3% 13.29%
OCF Margin 12.2% 8.7% 14.0% 11.3% 4.5% 1.9% -2.0% 13.4% 18.6% 24.1% 25.7% 24.8% 23.7% 28.2% 34.1% 34.6% 35.6% 35.3% 16.4% 15.1% 15.06%
ROE 3Y Avg snapshot only 15.86%
ROE 5Y Avg snapshot only 9.39%
ROA 3Y Avg snapshot only 10.02%
ROIC 3Y Avg snapshot only 14.68%
ROIC Economic snapshot only 2.38%
Cash ROA snapshot only 5.72%
Cash ROIC snapshot only 9.22%
CROIC snapshot only 8.14%
NOPAT Margin snapshot only 4.78%
Pretax Margin snapshot only 5.84%
R&D / Revenue snapshot only 23.45%
SGA / Revenue snapshot only 50.44%
SBC / Revenue snapshot only -1.00%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -54.31 -78.15 -69.34 -51.84 -28.41 -27.13 -28.34 52.14 22.42 13.27 10.78 14.27 14.02 13.05 15.80 13.82 14.92 19.54 38.48 132.03 110.132
P/S Ratio 4.41 3.21 3.56 4.16 3.24 3.86 4.15 3.67 3.03 2.84 2.71 2.73 3.11 3.08 3.68 3.20 3.32 3.20 3.76 5.24 4.465
P/B Ratio 4.54 3.38 3.98 4.51 3.52 4.11 4.63 4.19 3.55 3.92 3.73 3.21 3.62 3.27 3.69 2.96 2.92 2.60 3.36 4.83 4.089
P/FCF 43.97 51.08 30.38 47.88 259.62 -249.50 -78.53 33.77 18.95 13.36 11.88 12.60 14.83 11.81 11.57 10.04 10.30 9.83 26.50 39.39 39.389
P/OCF 36.07 37.01 25.36 36.65 71.90 204.05 — 27.38 16.31 11.76 10.55 11.02 13.13 10.91 10.78 9.25 9.34 9.07 22.94 34.76 34.758
EV/EBITDA 658.97 72.07 188.57 -297.72 -63.36 -53.21 -110.41 17.75 9.81 6.71 6.23 7.02 7.94 8.31 10.20 8.61 9.22 10.49 25.13 44.24 44.241
EV/Revenue 4.28 3.10 3.48 4.03 3.10 3.66 3.97 3.37 2.71 2.60 2.50 2.40 2.75 2.64 3.15 2.57 2.64 2.35 4.45 5.78 5.784
EV/EBIT -68.64 -129.74 -74.53 -49.75 -26.05 -26.35 -37.80 24.56 11.87 7.60 6.87 7.81 8.61 8.82 10.85 9.20 9.90 11.43 29.28 61.67 61.673
EV/FCF 42.73 49.45 29.69 46.36 248.36 -236.19 -75.05 31.00 16.96 12.22 10.93 11.04 13.11 10.14 9.89 8.07 8.18 7.23 31.32 43.52 43.521
Earnings Yield -1.8% -1.3% -1.4% -1.9% -3.5% -3.7% -3.5% 1.9% 4.5% 7.5% 9.3% 7.0% 7.1% 7.7% 6.3% 7.2% 6.7% 5.1% 2.6% 0.8% 0.76%
FCF Yield 2.3% 2.0% 3.3% 2.1% 0.4% -0.4% -1.3% 3.0% 5.3% 7.5% 8.4% 7.9% 6.7% 8.5% 8.6% 10.0% 9.7% 10.2% 3.8% 2.5% 2.54%
EV/OCF snapshot only 38.405
EV/Gross Profit snapshot only 6.841
Acquirers Multiple snapshot only 82.249
Shareholder Yield snapshot only 0.67%
Graham Number snapshot only $9.85
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 2.32 2.25 2.19 2.39 2.24 2.27 2.25 2.87 2.91 2.86 3.20 2.99 3.45 3.04 3.33 3.23 3.67 3.55 2.27 2.30 2.300
Quick Ratio 2.02 1.93 1.86 2.03 1.89 1.91 1.88 2.48 2.53 2.50 2.77 2.61 3.03 2.65 2.92 2.85 3.27 3.19 1.70 1.85 1.849
Debt/Equity 0.38 0.37 0.40 0.39 0.40 0.36 0.39 0.30 0.28 0.31 0.29 0.29 0.28 0.05 0.05 0.04 0.04 0.04 0.90 0.87 0.870
Net Debt/Equity -0.13 -0.11 -0.09 -0.14 -0.15 -0.22 -0.21 -0.34 -0.37 -0.33 -0.30 -0.40 -0.42 -0.46 -0.54 -0.58 -0.60 -0.69 0.61 0.51 0.506
Debt/Assets 0.21 0.21 0.22 0.22 0.22 0.19 0.20 0.18 0.17 0.17 0.17 0.17 0.17 0.04 0.04 0.03 0.03 0.03 0.37 0.36 0.358
Debt/EBITDA 57.18 8.23 19.48 -26.85 -7.60 -4.97 -9.78 1.40 0.88 0.58 0.54 0.72 0.70 0.15 0.16 0.16 0.16 0.21 5.72 7.21 7.212
Net Debt/EBITDA -19.13 -2.38 -4.40 9.75 2.87 3.00 5.12 -1.58 -1.15 -0.62 -0.54 -0.99 -1.04 -1.37 -1.73 -2.09 -2.39 -3.78 3.87 4.20 4.201
Interest Coverage -6.60 -2.50 -5.84 -9.94 -12.62 -11.83 -7.36 10.40 16.70 24.68 26.45 19.28 20.02 20.65 26.44 39.55 87.27 24.74 7.15 2.65 2.647
Equity Multiplier 1.82 1.82 1.84 1.81 1.86 1.88 1.91 1.71 1.68 1.78 1.69 1.72 1.67 1.40 1.38 1.39 1.34 1.39 2.43 2.43 2.429
Cash Ratio snapshot only 0.992
Debt Service Coverage snapshot only 3.690
Cash to Debt snapshot only 0.418
FCF to Debt snapshot only 0.141
Defensive Interval snapshot only 314.2 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.58 0.59 0.62 0.60 0.57 0.56 0.57 0.71 0.75 0.81 0.85 0.69 0.68 0.74 0.72 0.68 0.68 0.64 0.49 0.50 0.502
Inventory Turnover 1.43 1.43 1.46 1.49 1.43 1.31 1.30 1.31 1.32 1.38 1.32 1.31 1.32 1.33 1.24 1.16 1.11 1.04 0.80 1.05 1.049
Receivables Turnover 4.07 3.99 4.87 4.32 4.14 4.20 4.32 5.04 5.35 7.47 5.90 4.30 4.27 5.72 4.77 4.17 4.22 4.55 4.30 4.11 4.111
Payables Turnover 3.12 3.88 6.63 5.95 6.22 4.93 6.82 3.63 3.94 5.14 4.44 2.66 4.08 4.41 3.45 2.20 4.04 2.56 2.58 2.13 2.127
DSO 90 91 75 84 88 87 85 72 68 49 62 85 85 64 77 87 87 80 85 89 88.8 days
DIO 256 255 249 246 256 278 280 279 276 265 276 278 276 275 295 315 328 353 455 348 347.9 days
DPO 117 94 55 61 59 74 54 101 93 71 82 137 89 83 106 166 90 143 142 172 171.6 days
Cash Conversion Cycle 228 253 269 269 285 290 311 250 252 243 256 226 272 256 266 236 325 290 398 265 265.1 days
Fixed Asset Turnover snapshot only 5.665
Operating Cycle snapshot only 436.7 days
Cash Velocity snapshot only 2.540
Capital Intensity snapshot only 2.634
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue -3.6% 13.0% 15.0% 6.7% 0.2% -5.3% -6.7% 24.6% 40.6% 49.6% 54.0% 3.1% -5.4% -6.4% -12.3% -0.2% 1.1% -5.2% 3.2% 10.8% 10.79%
Net Income -24.6% 56.6% 34.8% -49.9% -40.9% -2.3% -1.7% 2.1% 2.7% 3.2% 3.6% 1.8% 55.2% 3.2% -18.8% 20.7% 1.6% -34.2% -56.7% -81.0% -81.02%
EPS -22.8% 57.3% 36.0% -49.9% -38.4% -2.2% -1.6% 2.0% 2.6% 3.2% 3.5% 1.8% 59.8% 5.4% -16.8% 22.6% 0.7% -35.0% -56.0% -80.8% -80.82%
FCF 11.1% 81.4% 2.0% 14.5% -87.5% -1.2% -1.4% 56.0% 17.0% 21.5% 7.7% 1.1% 24.0% 14.8% 22.2% 46.7% 55.7% 18.4% -53.9% -53.8% -53.81%
EBITDA -78.8% 9.4% 2.3% -1.4% -8.5% -2.5% -2.8% 18.5% 8.9% 9.4% 18.2% 85.3% 18.4% -23.1% -32.5% -12.5% -16.3% -33.1% -40.8% -51.6% -51.56%
Op. Income 31.9% 74.0% 56.9% -46.6% -91.2% -3.9% -2.2% 3.4% 3.8% 4.8% 5.7% 1.2% 28.8% -21.8% -34.0% -11.1% -17.9% -39.6% -50.9% -68.7% -68.66%
OCF Growth snapshot only -51.79%
Asset Growth snapshot only 95.01%
Equity Growth snapshot only 11.32%
Debt Growth snapshot only 20.64%
Shares Change snapshot only -1.04%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 2.3% 2.4% 3.2% 3.2% 1.8% -1.7% -2.1% 8.0% 10.7% 17.0% 18.2% 11.1% 10.0% 9.9% 8.0% 8.7% 10.4% 9.9% 11.7% 4.5% 4.48%
Revenue 5Y 10.2% 9.5% 9.0% 7.8% 6.1% 4.2% 3.7% 7.4% 8.6% 8.7% 9.6% 7.2% 7.0% 5.9% 4.9% 5.3% 5.4% 7.3% 8.4% 8.7% 8.68%
EPS 3Y — — — — — — — — — — — — — — — — — — — -12.9% -12.89%
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — -13.7% -13.73%
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y 26.4% — — — — — — — 1.3% — 3.7% 1.4% 3.1% 1.1% 1.8% — — — — -7.7% -7.75%
EBITDA 5Y — — — — — — — 3.1% 1.6% — — — — — — — 66.0% — 1.1% 42.9% 42.87%
Gross Profit 3Y 2.0% 2.1% 2.6% 2.5% 0.8% -3.4% -3.8% 8.0% 11.0% 17.9% 19.1% 10.9% 9.9% 10.4% 8.9% 10.2% 12.7% 12.7% 14.6% 4.5% 4.49%
Gross Profit 5Y 10.8% 9.7% 9.2% 7.9% 5.8% 3.6% 3.0% 7.5% 8.8% 9.0% 10.0% 7.2% 7.0% 5.8% 4.8% 5.5% 5.8% 8.3% 9.2% 8.9% 8.92%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — -14.7% -14.72%
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y 1.8% 35.2% 24.0% 73.6% 0.4% — — — — 1.1% 1.0% 54.3% 40.7% 76.6% 50.7% 67.6% 2.3% — — 11.7% 11.71%
FCF 5Y — — — — — — — — 1.2% 63.9% 39.8% 75.8% 86.5% — — — — 63.9% 36.1% 20.0% 20.00%
OCF 3Y 22.7% 0.8% 4.3% 12.7% -17.4% -33.7% — 90.6% 72.4% 69.2% 78.5% 48.0% 37.1% 62.8% 45.3% 57.6% 1.2% 1.9% — 8.6% 8.61%
OCF 5Y — — — — — 1.9% — 26.4% 31.6% 32.2% 24.5% 32.1% 31.5% 43.5% 1.2% 79.0% 56.5% 44.4% 26.9% 16.8% 16.82%
Assets 3Y 4.3% 3.5% 4.0% 3.8% 3.4% 2.8% 1.7% 6.7% 6.7% 3.1% 4.2% 4.4% 2.6% 0.5% 1.7% 4.8% 6.3% 8.8% 30.3% 26.2% 26.17%
Assets 5Y 3.2% 3.2% 2.7% 2.5% 2.1% 1.8% 2.1% 4.5% 5.3% 3.2% 3.9% 4.7% 4.2% 2.6% 2.7% 4.6% 4.4% 5.4% 17.8% 17.8% 17.79%
Equity 3Y -1.6% -1.7% -0.8% -0.3% -0.8% -1.3% -1.8% 6.4% 7.7% 4.1% 6.1% 5.4% 5.6% 9.6% 12.0% 14.5% 18.5% 20.3% 20.3% 12.2% 12.20%
Book Value 3Y -2.9% -2.8% -2.1% -1.7% -2.2% -2.7% -3.2% 3.8% 5.0% 1.8% 3.3% 3.9% 4.4% 8.6% 10.6% 13.5% 17.5% 19.3% 20.1% 13.3% 13.30%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.81 0.66 0.67 0.79 0.72 0.47 0.40 0.67 0.53 0.46 0.48 0.81 0.68 0.53 0.44 0.79 0.60 0.60 0.61 0.89 0.893
Earnings Stability 0.67 0.64 0.89 0.71 0.28 0.14 0.15 0.68 0.52 0.48 0.47 0.84 0.77 0.73 0.63 0.90 0.79 0.61 0.43 0.41 0.410
Margin Stability 0.98 0.99 0.98 0.98 0.98 0.98 0.98 0.99 0.98 0.98 0.98 0.99 0.98 0.98 0.98 0.98 0.98 0.97 0.97 0.99 0.991
Rev. Growth Consistency 0.00 0.50 0.50 0.50 0.50 0.00 0.00 1.00 1.00 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.50 0.00 0.50 0.50 0.500
Earn. Growth Consistency 0.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 1.00 1.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 1 1 1 1 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.90 0.50 0.86 0.80 0.84 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.92 0.99 0.86 0.50 0.50 0.500
Earnings Smoothness — — — — — — — — — — — 0.05 0.57 0.97 0.79 0.81 0.98 0.59 0.21 0.00 0.000
ROE Trend 0.04 0.10 0.05 0.00 -0.05 -0.08 -0.09 0.15 0.26 0.39 0.46 0.23 0.24 0.18 0.14 0.06 -0.01 -0.14 -0.20 -0.18 -0.183
Gross Margin Trend -0.00 -0.01 -0.02 -0.02 -0.03 -0.03 -0.03 0.02 0.03 0.03 0.04 0.00 0.00 0.02 0.02 0.01 0.02 0.02 0.02 0.00 0.003
FCF Margin Trend 0.10 0.05 0.13 0.07 -0.03 -0.07 -0.13 0.02 0.10 0.19 0.20 0.12 0.12 0.16 0.23 0.16 0.14 0.09 -0.13 -0.13 -0.135
Sustainable Growth Rate — — — — — — — 8.7% 17.9% 28.8% 35.5% 20.0% 22.7% 27.5% 25.5% 24.0% 22.4% 14.7% 9.4% 3.9% 3.85%
Internal Growth Rate — — — — — — — 5.2% 11.3% 18.7% 24.8% 13.2% 15.7% 21.2% 20.2% 18.5% 17.8% 11.8% 5.1% 2.0% 2.03%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income -1.51 -2.11 -2.73 -1.41 -0.40 -0.13 0.13 1.90 1.37 1.13 1.02 1.30 1.07 1.20 1.47 1.50 1.60 2.15 1.68 3.80 3.799
FCF/OCF 0.82 0.72 0.83 0.77 0.28 -0.82 2.70 0.81 0.86 0.88 0.89 0.87 0.89 0.92 0.93 0.92 0.91 0.92 0.87 0.88 0.882
FCF/Net Income snapshot only 3.352
OCF/EBITDA snapshot only 1.152
CapEx/Revenue 2.2% 2.4% 2.3% 2.7% 3.3% 3.4% 3.3% 2.5% 2.6% 2.9% 2.9% 3.1% 2.7% 2.1% 2.3% 2.7% 3.3% 2.7% 2.2% 1.8% 1.77%
CapEx/Depreciation snapshot only 0.479
Accruals Ratio -0.12 -0.08 -0.12 -0.12 -0.09 -0.09 -0.07 -0.04 -0.04 -0.02 -0.00 -0.04 -0.01 -0.03 -0.08 -0.08 -0.09 -0.12 -0.03 -0.06 -0.056
Sloan Accruals snapshot only -0.099
Cash Flow Adequacy snapshot only 8.506
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.7% 0.7% 0.8% 0.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.19 $0.19 $0.19 $0.20 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — 0.0% 0.0% 9.2% 7.5% 11.4% 9.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% — — 0.0% 0.0% 9.3% 8.3% 10.0% 10.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio — — — — — — — 1.1% 0.8% 10.3% 14.9% 51.8% 79.3% 62.5% 57.0% 33.2% 0.0% 12.8% 38.5% 88.8% 88.82%
Div. Increase Streak — — — — — — — — — 0 0 0 0 — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.3% 0.4% 0.5% 0.5% 0.6% 0.4% 0.0% 0.0% 0.0% 0.1% 0.7% 2.8% 5.0% 4.8% 3.6% 2.4% 0.0% 0.7% 1.0% 0.7% 0.67%
Net Buyback Yield -0.2% -0.2% -0.0% 0.0% 0.0% -0.0% -0.4% -0.2% -0.2% -0.2% 0.1% 2.4% 4.6% 4.5% 3.0% 1.7% -0.6% -0.3% -25.2% 0.1% 0.06%
Total Shareholder Return -0.2% -0.2% -0.0% 0.0% 0.0% -0.0% -0.4% -0.2% -0.2% 0.5% 0.8% 3.2% 5.3% 4.5% 3.0% 1.7% -0.6% -0.3% -25.2% 0.1% 0.06%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.13 1.23 0.94 0.90 0.89 0.95 1.23 0.57 0.63 0.65 0.72 0.66 0.73 0.83 0.84 0.85 0.85 0.83 0.75 0.68 0.679
Interest Burden (EBT/EBIT) 1.15 1.40 1.17 1.10 1.08 1.08 1.14 0.90 0.94 0.96 0.96 0.95 0.95 0.95 0.96 0.97 0.99 0.96 0.86 0.62 0.622
EBIT Margin -0.06 -0.02 -0.05 -0.08 -0.12 -0.14 -0.10 0.14 0.23 0.34 0.36 0.31 0.32 0.30 0.29 0.28 0.27 0.21 0.15 0.09 0.094
Asset Turnover 0.58 0.59 0.62 0.60 0.57 0.56 0.57 0.71 0.75 0.81 0.85 0.69 0.68 0.74 0.72 0.68 0.68 0.64 0.49 0.50 0.502
Equity Multiplier 1.78 1.82 1.81 1.79 1.84 1.85 1.87 1.75 1.76 1.83 1.79 1.71 1.67 1.57 1.52 1.53 1.48 1.40 1.94 1.94 1.936
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.57 $-0.30 $-0.38 $-0.57 $-0.79 $-0.96 $-0.99 $0.60 $1.25 $2.09 $2.51 $1.69 $2.00 $2.20 $2.09 $2.07 $2.01 $1.43 $0.92 $0.40 $0.40
Book Value/Share $6.79 $6.87 $6.62 $6.61 $6.35 $6.35 $6.09 $7.46 $7.89 $7.07 $7.25 $7.51 $7.74 $8.80 $8.96 $9.65 $10.29 $10.78 $10.54 $10.85 $10.85
Tangible Book/Share $5.70 $5.84 $5.65 $5.70 $5.50 $5.62 $5.35 $6.81 $7.28 $6.57 $6.77 $7.02 $7.23 $8.29 $8.46 $9.15 $9.79 $10.28 $-3.78 $-3.28 $-3.28
Revenue/Share $6.99 $7.25 $7.39 $7.16 $6.89 $6.77 $6.79 $8.52 $9.25 $9.78 $9.98 $8.82 $9.01 $9.35 $8.97 $8.94 $9.03 $8.75 $9.40 $10.01 $10.01
FCF/Share $0.70 $0.46 $0.87 $0.62 $0.09 $-0.10 $-0.36 $0.93 $1.48 $2.08 $2.28 $1.91 $1.89 $2.44 $2.85 $2.85 $2.91 $2.85 $1.33 $1.33 $1.33
OCF/Share $0.85 $0.63 $1.04 $0.81 $0.31 $0.13 $-0.13 $1.14 $1.72 $2.36 $2.57 $2.19 $2.13 $2.64 $3.06 $3.09 $3.21 $3.09 $1.54 $1.51 $1.51
Cash/Share $3.47 $3.31 $3.25 $3.55 $3.53 $3.70 $3.64 $4.83 $5.17 $4.55 $4.31 $5.12 $5.44 $4.51 $5.24 $6.03 $6.59 $7.82 $3.08 $3.94 $3.94
EBITDA/Share $0.05 $0.31 $0.14 $-0.10 $-0.34 $-0.46 $-0.24 $1.62 $2.56 $3.78 $4.00 $3.01 $3.12 $2.97 $2.77 $2.67 $2.59 $1.96 $1.66 $1.31 $1.31
Debt/Share $2.60 $2.57 $2.66 $2.60 $2.56 $2.31 $2.39 $2.27 $2.24 $2.19 $2.14 $2.15 $2.19 $0.45 $0.44 $0.43 $0.42 $0.41 $9.52 $9.44 $9.44
Net Debt/Share $-0.87 $-0.74 $-0.60 $-0.94 $-0.97 $-1.39 $-1.25 $-2.56 $-2.93 $-2.36 $-2.17 $-2.97 $-3.25 $-4.06 $-4.80 $-5.60 $-6.17 $-7.40 $6.44 $5.50 $5.50
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 2.504
Altman Z-Prime snapshot only 4.477
Piotroski F-Score 3 5 5 5 3 4 3 8 8 7 8 8 6 8 7 8 6 6 5 4 4
Beneish M-Score -2.88 -2.53 -2.84 -3.14 -3.04 -2.98 -2.92 -2.05 -2.37 -2.54 -2.41 -2.35 -2.55 -2.51 -2.90 -2.96 -2.99 -3.26 -0.83 -0.83 -0.830
Ohlson O-Score snapshot only -6.915
Net-Net WC snapshot only $-6.37
EVA snapshot only $-192766380.52
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB-
Credit Score 50.47 39.65 47.54 61.09 48.41 47.89 50.41 90.43 89.66 94.38 94.42 89.79 94.20 95.33 94.90 94.83 94.65 94.73 59.82 53.47 53.466
Credit Grade snapshot only 10
Credit Trend snapshot only -41.362
Implied Spread (bps) snapshot only 350.000
Industry Credit Rank snapshot only 41
Sector Credit Rank snapshot only 47

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms